Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial.

Zhao, Ying; Griesel, Rulan; Omar, Zaayid; Simmons, Bryony; Hill, Andrew; van Zyl, Gert; Keene, Claire; Maartens, Gary; Meintjes, Graeme

Zhao, Ying; Griesel, Rulan; Omar, Zaayid; Simmons, Bryony; Hill, Andrew; van Zyl, Gert; Keene, Claire; Maartens, Gary; Meintjes, Graeme.

Afiliação

Zhao Y; Department of Medicine.
Griesel R; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine.
Omar Z; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine.
Simmons B; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.
Hill A; Department of Medicine.
van Zyl G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine.
Keene C; LSE Health, London School of Economics and Political Science.
Maartens G; Department of Pharmacology and Therapeutics, University of Liverpool, United Kingdom.
Meintjes G; Division of Medical Virology, Stellenbosch University, South Africa.

Clin Infect Dis ; 76(10): 1832-1840, 2023 05 24.

Article em En | MEDLINE | ID: mdl-36645792

Assuntos

Infecções por HIV; Lamivudina; Adulto; Humanos; Lamivudina/uso terapêutico; Antirretrovirais; Benzoxazinas; Tenofovir; Emtricitabina; RNA; Infecções por HIV/tratamento farmacológico

Palavras-chave

HIV; antiretroviral therapy; dolutegravir; efavirenz; second-line

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Lamivudina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Lamivudina Idioma: En Ano de publicação: 2023 Tipo de documento: Article